|
US2006237016A1
|
|
Dry powder inhaler
|
|
DE102004058337A1
|
|
Process for the preparation of fused piperazin-2-one derivatives
|
|
US2005061705A1
|
|
Pharmaceutical blister
|
|
US6685691B1
|
|
Container for a medicinal liquid
|
|
US5922878A
|
|
Amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
|
|
US5633002A
|
|
Implantable, biodegradable system for releasing active substance
|
|
AU5108593A
|
|
Calcium polycarbophil preparations which allow the active ingredient to be taken in large doses
|
|
US5302694A
|
|
Process for preparing polyesters based on hydroxycarboxylic acids
|
|
US5270037A
|
|
Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
|
|
DE4232154A1
|
|
Solid medicine dispenser - has mobile closure with recess accommodating single dosage unit
|
|
US5225107A
|
|
Nucleating agents (pore regulators) for the preparation of directly gassed thermoplastic foams
|
|
US5212321A
|
|
Process for the preparation of trimethylene carbonate
|
|
US5175157A
|
|
Cyclic amine derivatives, pharmaceutical compositions containing these compounds and methods for preparing them
|
|
US5149833A
|
|
Process for preparing D,L-Lactide
|
|
US5223614A
|
|
New quaternary ammonium compounds, their preparation and use
|
|
US5214159A
|
|
Meso-lactide
|
|
DD296491A5
|
|
New hetrazepine with paf antagonistic effect, method for the production thereof and their use as a medicament
|
|
US5215744A
|
|
Methods for the treatment of tumors
|
|
SU1681729A3
|
|
Method for preparation of 1,4-benzodiazepine derivatives
|
|
IE862238L
|
|
Amino acid derivatives of heterocyclic compounds
|
